Results 61 to 70 of about 18,563 (231)

Incidental finding of Psuedomyxoma Peritonei in Malignant Peripheral Nerve Sheath Tumour

Journal of the Pakistan Medical Association
Psuedomyxoma peritonei is an infrequent clinical entity characterised by intraperitoneal mucinous/gelatinous ascites produced by the cancerous cells. It has been associated with gastrointestinal, gynaecological, lung and breast tumours.
Sana Munir Gill, Mariyam Waseem, Humayun Bashir, Aamna Hassan   +3 more
doaj   +1 more source

Mucinous Carcinomatosis: A Rare Association between an Ovarian Tumor and an E-GIST

Case Reports in Surgery, 2018
Pseudomyxoma peritonei (PMP) and extragastrointestinal stromal tumors (E-GISTs) are both rare entities. Most of the time, PMP is associated with an appendiceal tumor. An ovarian mucinous tumor can mimic appendiceal metastases.
Hugo Palma Rios, André Goulart, Pedro Leão   +2 more
doaj   +1 more source

Incidental Finding of Pseudomyxoma Peritonei in a Patient Presenting with Umbilical Hernia [PDF]

Walawalkar International Medical Journal, 2020
Background: Pseudomyxoma peritonei (PMP) was first described by Rokitansky in 1842.1Werth described the association with ovarian tumors in 1884 and Franckel reported its association with appendiceal cystic tumours in 1901.
Sameer Kadam, Ajit Nehete, Pooja Dandekar, Abhay Desai, Vijay Dombale   +4 more
doaj   +2 more sources

Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei [PDF]

, 2018
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The aim of this work is to evaluate the efficacy of cytoreductive surgery alone versus cytoreductive surgery in combination with hyperthermic intraperitoneal ...
Ma, Huaixing, Mahteme, Haile, Mocellin, Simone, Pasquali, Sandro, Sommariva, Antonio, Steenberg, Josephine L., Suo, Tao, Tropea, Saveria   +7 more
core   +1 more source

Abnormal DNA Methylation Profile Suggests the Extension of the Clinical Spectrum of the SETD2 ‐Related Disorders to a Syndromic Multiple Tumor Phenotype

American Journal of Medical Genetics Part A, Volume 197, Issue 7, July 2025.
ABSTRACT SETD2 has an essential role in epigenetic regulation. SETD2 pathogenic variants cause neurodevelopmental disorders (SETD2‐NDDs) that most commonly include various degrees of intellectual disability and behavioral disorders, macrocephaly, brain malformations, and generalized overgrowth.
Marie Lucain, Antonio Vitobello, Bekim Sadikovic, Juliette Albuisson, Léa Gaudillat, Martin Chevarin, Julien Maraval, Christel Thauvin‐Robinet, Jennifer Kerkhof, Christophe Philippe, Sophie Nambot, Laurence Faivre   +11 more
wiley   +1 more source

Pseudomyxoma peritonei - a report of two cases and a review of the literature [PDF]

, 2015
Introduction: PMP is a rare disease with a slow but progressive course leading to death. According to the literature PMP encompass wide variety of conditions.
Dimitrov, Dimitar, Dimov, Petko, Kjossev, Kirien, Mutafchiyski, Ventsislav, Popivanov, Georgi, Stefanov, Daniel   +5 more
core   +2 more sources

Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study [PDF]

, 2021
Ru Ma, Yu‐Lin Lin, Xin-Bao Li, Fengcai Yan, Hongbin Xu, Peng Zheng, Yan Li   +6 more
openalex   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

Cancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis, Timothy Kennedy, Sareena Singh, Gerard Abood, Eric Christenson, Christopher J. Anker, Dmitriy Akselrod, Christopher L. Hallemeier, Krishan R. Jethwa, Ed Kim, Percy Lee, Eric D. Miller, Neil B. Newman, J. Eva Selfridge, Navesh Sharma, William Small Jr, Leila Tchelebi, Vonetta M. Williams, Suzanne Russo   +18 more
wiley   +1 more source

Mucinous ascites

Journal of Hospital Medicine, Volume 21, Issue 1, Page 118-119, January 2026.
Miguel Buendia, Lara Voigt, John M. Cunningham   +2 more
wiley   +1 more source

Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study

Cancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Introduction Cancer patients face a 4 to 7‐fold higher risk of developing thrombotic events compared to individuals without cancer. This elevated risk is driven by the underlying tumour biology and the effects of cancer treatments, significantly increasing the mortality rates of these patients.
H. Macleod, N. Copty, D. Doherty, L. Weiss, E. Fouhy, R. Power, N. Ryan, K. Saeed, E. ORourke, R. Faryal, S. Kelliher, B. Kevane, F. Ní Áinle, P. B. Maguire   +13 more
wiley   +1 more source